3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
7
Triple Negative Breast Neoplasms
5
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasm Metastasis
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Neoplasms
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Melanoma, Cutaneous Malignant
1
Head and Neck Neoplasms
1
GastroEsophageal Cancer
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Pancreatic Ductal
1
CLDN18.2 Positive
1
Anal Cancer Metastatic
1
Adenocarcinoma
1
Interventions
ribociclib
2
Specimen Handling
2
tucatinib
1
trastuzumab biosimilar HLX02
1
pertuzumab
1
exemestane
1
durvalumab
1
Trastuzumab
1
Taxes
1
Paclitaxel
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Immunoglobulin G
1
Genetic Testing
1
Fulvestrant
1
Drug Therapy
1
Doxorubicin
1
Docetaxel
1
Disulfides
1
Cyclophosphamide
1
Carboplatin
1
Anastrozole
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage II Breast Cancer AJCC v8
×
Albumin-Bound Paclitaxel
×
30 days
×
Clear all
No trials found.